Skip to main content

Kodiak Sciences Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Fair Value Measurements

  1. Fair Value Measurements

The following tables present the Company’s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):

Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$207,585$—$—$207,585
Total cash equivalents207,585——207,585
Cash2,277——2,277
Total cash and cash equivalents$209,862$—$—$209,862
Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$166,464$—$—$166,464
Total cash equivalents166,464——166,464
Cash1,610——1,610
Total cash and cash equivalents$168,074$—$—$168,074

As of December 31, 2025 and 2024, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (“BBA”), which are considered Level 3 inputs. See Note 15.

As discussed in Note 8, the Company entered into a sublease agreement during the first quarter of 2025, which led to an impairment of the related right-of-use asset. Estimated fair value of the right-of-use asset was based on expected sublease rental income, considering current sublease market conditions, discounted at a market rate of return on similar assets. The estimates and assumptions used are considered Level 3 inputs.

There wereno transfers of assets or liabilities between the fair value measurement levels during the years ended December 31, 2025 and 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.